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The clinical need to evaluate myocardial perfusion is not
satisfied by conventional imaging techniques (I). Angiog-
raphy is frequently used to provide qualitative anatomic
data, but it lacks a physiologic basis for assessing regional
blood flow and is an unreliable predictor of it (2,3). Recent
technical advances in contrast echocardiography permit di-
rect perfusion assessment and promise to provide a safe.
convenient and economical alternative to more invasiveand
costly imaging techniques.
Clinical Applications of Contrast
Echocardiography
The recent development of small, stable sonicated mi-
crobubble contrast agents permits myocardial blood flow
assessment in patients undergoing cardiac catheterization,
angioplasty and thrombolytic revascularization procedures
(4,5). Now the effects of therapeutic interventions can be
monitored on the basis of direct, real-time, tomographic
data.
Early microbubble contrast agents were created by hand
agitation (6). Virtually all noninvasive laboratories use hand-
agitated microbubbles for right heart contrast echocardio-
graphic studies of valve regurgitation (6-9), cavity dimen-
sion (10.11) and shunt detection (12). In addition, several
laboratories use hand-agitated microbubbles to assess per-
fusion during cardiac catheterization or open heart surgery
(13,14); however, dynamic physiologic assessments of blood
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flow have been limited because of the relatively large size
and instability of the microbubbles. Nevertheless. the rel-
ative safety of hand-agitated microbubbles has been ac-
knowledged (15) and their hemodynamic and histologic ef-
fects have been studied (16).
We have developed sonicated microbubbles that are smaller
than hand-agitated microbubbles and. in fact, are smaller
than red blood cells (17). This enables them to flow with
the red blood cells through the microvasculature (18) at
physiologic transit times. Sonicated microbubbles are ex-
cellent ultrasound reflectors because of the acoustic imped-
ance of the liquid-gas interface. They are produced by ap-
plying ultrasound energy to a nontoxic solution and generating
first generation cavitation bubbles that ultimately collapse
and produce the second generation "by-product" bubbles
used as contrast material. Their small size and reproduc-
ibility have been confirmed by light microscopy (17) and
in situ laser and Coulter counter analyses (19). In addition,
we have used electromagnetic flowmeters to correlate ar-
terial blood flow patterns with sonicated microbubble flow
patterns measured by videodensitometry during perfusion
studies of the dog heart (20) and kidney (21). A decrease
in arterial blood flow consistently resulted in a prolonged
videodensitornetric signal.
Our laboratory has used sonicated Renografin-76 mi-
crobubbles without complication in more than 60 patients
undergoing cardiac catheterization (4). Direct intracoronary
injections were performed through a catheter. using 1.5
to 2 ml of the sonicated solution. Microbubbles measured
3.8 ± 2.1 JL in diameter. using laser analysis. The contrast
echocardiographic portion of the procedure added only min-
imally to the entire time required. Results included blood
flow information not otherwise available.
In our contrast echocardiographicperfusion studies, tran-
sient 15 second hemodynamic or electrocardiographic
changes, or both, were observed. These transient effects
were likely a consequence of the properties of the carrier
solution, rather than the presence of the microbubbles; stud-
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of tissue with sonicated microbubbles indicated that the
agent and the volume delivered, as opposed to the presence
of the microbubbles, were the dominant factors affecting
the heart rate, blood pressure, electrocardiogram and epi-
cardial blood flow (22).
Future Applications: Intravenous
Screening Procedure
Perfusion screening studies outside the catheterization
laboratory and operating room will require the development
of a contrast agent capable of transpulmonary transit from
a peripheral venous injection site. Intravenous perfusion
screening would present several advantages over current
imaging techniques. No arterial invasion or X-ray exposure
would be required. Ultrasound equipment is economical,
widely available and relatively simple to operate. In addi-
tion, serial and follow-up studies would be feasible. An
intravenous procedure could potentially be performed in a
physician's office, outpatient clinic, emergency room or
cardiac care unit. This would markedly broaden the infor-
mation available in both routine and emergency situations.
Our laboratory (23) recently found that sonicated albumin
microspheres pass intact from a peripheral venous injection
site in sufficient numbers to permit real-time myocardial
perfusion imaging in the monkey, dog and pig. The albumin
microspheres are 2 to 4 JL in diameter, and traverse the
capillary vasculature in a manner physiologically similar to
that of red blood cells. They also are isomotic to human
serum, biodegradable and stable and echogenic for days.
Quantitation of Blood Flow
Measuring blood flow within tissue depends in part on
understanding the mathematic relation between microbubble
size and concentration and reflected ultrasound energy. We
have used direct radiofrequency analysis in vitro to dem-
onstrate the mathematic relation between known concentra-
tions and diameters of sonicated microbubbles and reflected
energy (24,25). Thes calculations serve as a basis for quan-
titating blood flow by ultrasound.
In addition, current commercial ultrasound equipment
needs to be redesigned to permit direct access of the entire
dynamic range of reflected energy, without compression and
postprocessing distortion. Design modifications are being
implemented using an on-line, digital ultrasound format based
on earlier ultrasound tissue characterization techniques
(26-28). Ultimately, quantitative contrast echocardiography
may complement tissue characterization techniques by pro-
viding images of perfusion of ischemic or infarcted regions
not otherwise characterized by sector scan two-dimensional
echocardiography or traditional ultrasound tissue character-
ization techniques.
Conclusion
Contrast echocardiography promises to satisfy the clin-
ical need for direct images of regional blood flow, linking
coronary anatomy and physiology. The development of small,
stable and reproducible sonicated microbubbles currently
permits perfusion imaging during cardiac catheterization,
angioplasty and surgery. In addition, with further devel-
opment and validation of intravenous contrast agents, con-
trast echocardiography may in the future be used in non-
invasive imaging procedures yielding quantitative regional
perfusion data. Clinical trials will be designed to monitor
the efficacy of therapies used in patient management. Ul-
timately, whether used alone as a screening or follow-up
procedure, or in combination with interventional therapy,
contrast echocardiography would affect the management of
ischemic heart disease by providing perfusion data in a
manner that is relatively simple, safe and widely available.
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